Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Return on Capital Employed (2021 - 2025)

Bolt Biotherapeutics' Return on Capital Employed history spans 5 years, with the latest figure at 0.76% for Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 1.0% year-over-year to 0.76%; the TTM value through Sep 2025 reached 0.76%, up 1.0%, while the annual FY2024 figure was 0.64%, 20.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.76% at Bolt Biotherapeutics, up from 0.8% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.23% in Q2 2021 and bottomed at 0.86% in Q1 2025.
  • The 5-year median for Return on Capital Employed is 0.45% (2023), against an average of 0.52%.
  • The largest annual shift saw Return on Capital Employed plummeted -31bps in 2024 before it increased 1bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.31% in 2021, then tumbled by -36bps to 0.42% in 2022, then fell by -22bps to 0.52% in 2023, then plummeted by -59bps to 0.82% in 2024, then grew by 8bps to 0.76% in 2025.
  • Per Business Quant, the three most recent readings for BOLT's Return on Capital Employed are 0.76% (Q3 2025), 0.8% (Q2 2025), and 0.86% (Q1 2025).